Sumatriptan.
Bateman
D N
DN
Regional Drug and Therapeutic Centre, Wolfson Unit, Newcastle upon Tyne, UK.
D000284:Administration, Oral; D002986:Clinical Trials as Topic; D006801:Humans; D007211:Indoles / Q000493:pharmacokinetics / Q000494:pharmacology / Q000627:therapeutic use*; D007279:Injections, Subcutaneous; D008881:Migraine Disorders / Q000188:drug therapy*; D012008:Recurrence; D017366:Serotonin Receptor Agonists / Q000493:pharmacokinetics / Q000494:pharmacology / Q000627:therapeutic use*; D013449:Sulfonamides / Q000493:pharmacokinetics / Q000494:pharmacology / Q000627:therapeutic use*; D018170:Sumatriptan; D016896:Treatment Outcome
D007211:Indoles; D017366:Serotonin Receptor Agonists; D013449:Sulfonamides; D018170:Sumatriptan